These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6164028)

  • 1. [13,14-Dihydro-15-keto prostaglandin F2 alpha and haptoglobin in the serum of patients with urogenital tumors].
    Dunzendorfer U; Ohlenschläger G; Zahradnik HP
    Onkologie; 1981 Feb; 4(1):10-6. PubMed ID: 6164028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 13,14-Dihydro-15-keto-prostaglandin F2 alpha in patients with urogenital tumors.
    Dunzendorfer U; Zahradnik HP; Gerster K
    Urol Int; 1980; 35(3):171-5. PubMed ID: 6155727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transferrin, C3 complement, haptoglobin, plasminogen and alpha 2-microglobulin in patients with urogenital tumors.
    Dunzendorfer U; Jung K; Ohlenschläger G
    Eur Urol; 1980; 6(4):232-6. PubMed ID: 6156074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence against the formation of 13,14-dihydro-15-keto-prostaglandin F2 alpha following inhalation of prostaglandin D2 in man.
    Hardy CC; Holgate ST; Robinson C
    Br J Pharmacol; 1986 Mar; 87(3):563-8. PubMed ID: 3467804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Perioperative behavior of prostaglandin E2 (PGE2) and 13,14-dihydro-15-keto-PGF2 alpha (DHK-PGF2 alpha) in the serum in bronchial cancer].
    Fiedler L; Schlegel G; Kaiser D; Zahradnik HP
    Onkologie; 1979 Jun; 2(3):108-12. PubMed ID: 392376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Indicators of alkaline phosphatase and peroxidase in the leukocytes of the peripheral blood in patients with cancer of the urogenital system].
    Matskiv AS; Zabolotskiĭ AT; Sultan NN
    Vrach Delo; 1973 Nov; 11():67-70. PubMed ID: 4132245
    [No Abstract]   [Full Text] [Related]  

  • 7. Half-life of 13,14-dihydro-15-keto prostaglandin f2 alpha in peripheral plasma of the pig.
    Martin KA; Liptrap RM
    Res Vet Sci; 1981 Nov; 31(3):387-9. PubMed ID: 7342231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of peptide hormones LH, FSH, TSH, prolactin, HCG, parathormone, calcitonin and prostaglandin F2 alpha in kidney neoplasms].
    Dunzendorfer U; Drahovsky D; Schmidt-Gayk H; Zahradnik HP
    Z Urol Nephrol; 1981 Jan; 74(1):13-9. PubMed ID: 6785940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostacyclin, thromboxane and prostaglandin F2 alpha; plasma levels in breast cancer.
    Vergote I; Laekeman G; Heiremans J; Becquart D; Buytaert P; Herman A
    Tumour Biol; 1986; 7(5-6):407-10. PubMed ID: 3554471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of plasma 6-keto-prostaglandin F1 alpha and 13,14-dihydro-15-keto-prostaglandin F2 alpha by aminoglutethimide in advanced breast cancer.
    Harris AL; Mitchell MD; Smith IE; Powles TJ
    Br J Cancer; 1983 Oct; 48(4):595-8. PubMed ID: 6688732
    [No Abstract]   [Full Text] [Related]  

  • 11. Perioperative behavior of prostaglandin E2 and 13,14-dihydro-15-keto-PGF2 alpha in serum of bronchial carcinoma patients.
    Fiedler L; Zahradnik HP; Schlegel G
    Adv Prostaglandin Thromboxane Res; 1980; 6():585-6. PubMed ID: 7386293
    [No Abstract]   [Full Text] [Related]  

  • 12. Oxytocin and initiation of human parturition. III. Plasma concentrations of oxytocin and 13,14-dihydro-15-keto-prostaglandin F2 alpha in spontaneous and oxytocin-induced labor at term.
    Fuchs AR; Goeschen K; Husslein P; Rasmussen AB; Fuchs F
    Am J Obstet Gynecol; 1983 Nov; 147(5):497-502. PubMed ID: 6638091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical studies of plasma PGF2 alpha M, the circulating prostaglandin F2 alpha metabolite.
    Walker V
    Clin Chim Acta; 1982 Sep; 124(3):327-37. PubMed ID: 7127845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum beta-2-microglobulin levels in urological cancer.
    Bunning RA; Haworth SL; Cooper EH
    J Urol; 1979 May; 121(5):624-5. PubMed ID: 86616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin F2 alpha in benign and malignant breast tumours.
    Vergote IB; Laekeman GM; Keersmaekers GH; Uyttenbroeck FL; Vanderheyden JS; Albertyn GP; Haensch CF; De Roy GJ; Herman AG
    Br J Cancer; 1985 Jun; 51(6):827-36. PubMed ID: 3859318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of 13, 14-dihydro-15-keto-prostaglandin F2 alpha (PGF2 alpha M) in patients with endometriosis.
    Wang YF; Han ML; Sun AD; Huang RL; Zhang H; Ma XH; Cheng JX; Duan JH
    Proc Chin Acad Med Sci Peking Union Med Coll; 1987; 2(2):107-10. PubMed ID: 3423006
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in plasma oxytocin, prostaglandin E1, and 13,14-dihydro-15-keto-prostaglandin F2 alpha during labor induced by prostaglandin E2 or F2 alpha and spontaneous labor.
    Nagata I; Seki K; Uesato T; Sunaga H; Furuya K; Makimura N; Kato K
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Sep; 39(9):1627-33. PubMed ID: 3479503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of vessels by lectin-immunoperoxidase staining of endothelium: possible applications in urogenital malignancies.
    Fujime M; Lin CW; Prout GR
    J Urol; 1984 Mar; 131(3):566-70. PubMed ID: 6199526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular staging of genitourinary malignancies.
    Katz AE; De Vries GM; Olsson CA; Benson MC; Swanton P; Ikeguchi EF; Buttyan R
    Urology; 1996 Jun; 47(6):948-58. PubMed ID: 8677601
    [No Abstract]   [Full Text] [Related]  

  • 20. The ovarian enzyme catalyzing conversion of 13,14-dihydro-15-ketoprostaglandin F2 alpha to 13,14-dihydroprostaglandin F2 alpha in rats.
    Inazu N; Kogo H; Satoh T
    Res Commun Chem Pathol Pharmacol; 1985 Jul; 49(1):149-52. PubMed ID: 4035077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.